Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20220689 20175296 1.7 78 Curative (C) 2016-03-01 2016-03-02 EOX 02 Y SORAFENIB 100739337
20220714 20175297 1.66 85.5 Palliative (P) 2020-09-25 2020-09-25 EOX 02 N CAPECITABINE + RT 101248078
20220715 20175298 1.53 62.1 null 2021-01-20 2021-03-07 Cetuximab + FOLFIRI cycle 2 onwards 2 null CETUXIMAB + IRINOTECAN + MDG 101790058
20220745 20175299 1.69 73.7 Neo-adjuvant (N) 2019-03-27 2019-03-31 CAPECITABINE + RT N Y CAPECITABINE + RT 100231340
20220747 20175300 1.79 63 null 2017-11-04 2018-10-07 Cetuximab + Oxaliplatin + MdG Maint 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101606636
20220778 20175301 1.79 85.9 Disease modification (D) 2018-09-10 2018-09-10 Capecitabine 42days + RT 02 Y CAPECITABINE + RT 100854304
20220796 20175302 1.64 66.1 Palliative (P) 2017-10-25 2018-07-15 EOX 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100424166
20220800 20175303 1.78 53.75 Palliative (P) 2020-02-23 2020-03-20 EOX 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100941969
20220820 20175304 1.6 77 Palliative (P) 2018-11-26 2018-12-02 EOX 02 N CAPECITABINE + RT 101817856
20220833 20175305 1.75 70.6 Neo-adjuvant (N) 2021-04-17 2021-04-24 EOX 02 N CETUXIMAB + IRINOTECAN + MDG 101740835
20220846 20175306 1.85 91.2 Palliative (P) 2018-10-03 2018-12-05 EOX N N TRIAL 100709450
20220864 20175307 1.78 102 Palliative (P) 2018-10-20 2018-11-21 EOX 2 N CAPECITABINE + RT 100086352
20220877 20175308 1.79 56.1 null 2017-10-20 2017-11-07 CAPECITABINE + RT 02 null CAPECITABINE + RT 100992867
20220896 20175309 1.5 79.6 Palliative (P) 2016-11-04 2016-11-21 CETUXIMAB + IRINOTECAN + MDG 02 N CETUXIMAB + IRINOTECAN + MDG 100136464
20220920 20175310 1.58 66 Palliative (P) 2017-05-29 2017-06-13 Trial Unspecified 02 N TRIAL 101122307
20220945 20175311 1.57 54.2 Palliative (P) null 2016-09-02 EOX 02 N EOX 100274288
20220996 20175312 0.76 57.4 Palliative (P) 2017-05-07 2017-05-15 EOX 99 N TRIAL 101819144
20221057 20175313 1.9 78.8 Neo-adjuvant (N) 2020-03-28 2020-04-11 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100264853
20221079 20175314 1.84 109 Curative (C) 2021-05-31 2021-06-28 CETUXIMAB + IRINOTECAN + MDG 01 Y CETUXIMAB + IRINOTECAN + MDG 101699760
20221095 20175315 0 91.4 Palliative (P) 2014-10-19 2016-08-02 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101445003
20221103 20175316 1.72 79.4 null 2016-04-28 2016-05-14 EOX N N TRIAL 101482232
20221104 20175317 1.58 81.9 Neo-adjuvant (N) 2017-02-02 2017-05-02 EOX N N TRIAL 100266547
20221110 20175318 1.93 72 null 2019-04-13 2019-04-13 CETUXIMAB + IRINOTECAN + MDG N N CETUXIMAB + IRINOTECAN + MDG 101718312
20221118 20175319 1.88 75.1 null 2017-01-11 2017-01-30 EOX 02 null TRIAL 100595490
20221140 20175320 1.44 72.2 null 2016-02-26 2017-02-22 Trial Unspecified 02 null TRIAL 100709637
20221148 20175321 1.6 77.7 null 2018-06-14 2018-06-16 Trial Unspecified Y N TRIAL 100887725
20221185 20175322 1.66 15.6 Palliative (P) 2017-03-23 2017-03-25 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101382602
20221187 20175323 1.86 70.3 Palliative (P) 2017-08-16 2018-04-11 Trial Unspecified 2 N TRIAL 100101027
20221295 20175324 1.67 74.9 Curative (C) 2018-09-28 2018-10-22 EOX N null CAPECITABINE + RT 101301235
20221297 20175325 1.75 75 Neo-adjuvant (N) 2018-02-14 2018-03-07 EOX Y null EOX 100123939
20221300 20175326 1.75 62 null 2017-06-01 2019-07-14 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101375907
20221413 20175327 1.62 48.6 Palliative (P) 2017-07-14 2018-09-01 EOX N N CETUXIMAB + IRINOTECAN + MDG 100575563
20221450 20175328 1.62 100.2 Palliative (P) 2018-08-16 2018-09-01 Oxaliplatin + Raltitrexed 02 null OXALIPLATIN + RALTITREXED 101030491
20221483 20175329 1.64 65.2 Palliative (P) 2020-07-29 2020-08-09 CETUXIMAB + IRINOTECAN + MDG 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100896888
20221496 20175330 1.83 74 Palliative (P) 2016-09-15 2016-09-15 CAPECITABINE + RT 02 N CAPECITABINE + RT 100410223
20221557 20175331 1.83 52.2 Palliative (P) 2016-03-13 2016-03-27 EOX 02 Y SORAFENIB 100470260
20221657 20175332 1.79 74 null 2019-06-12 2019-06-12 EOX 02 null EOX 101042109
20221713 20175333 1.6 87 Neo-adjuvant (N) 2018-05-01 2018-06-26 Trial Unspecified 02 N TRIAL 100830799
20221759 20175334 1.78 0 Palliative (P) 2018-03-23 2018-08-16 EOX 2 N EOX 100398377
20221814 20175335 1.6 73.8 Neo-adjuvant (N) 2019-04-18 2019-04-18 EOX 01 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101047669
20221853 20175336 1.86 56.3 null 2018-08-10 2018-08-10 IRINOTECAN + MDG + PANITUMUMAB 02 null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100772706
20221870 20175337 1.56 89.3 Palliative (P) 2018-02-19 2018-05-02 EOX N Y SORAFENIB 100876326
20221872 20175338 1.87 54 Palliative (P) 2018-05-20 2018-05-20 EOX N N CAPECITABINE + RT 101483998
20221892 20175339 1.82 71 Curative (C) 2017-06-04 2017-06-05 EOX N N EOX 100661654
20221911 20175340 1.72 86 Curative (C) 2016-04-16 2016-05-03 FLUOROURACIL + IRINOTECAN + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100526766
20221945 20175341 1.79 82 Palliative (P) 2019-01-19 2019-01-19 EOX 02 N EOX 100034724
20221947 20175342 1.7 54.9 Palliative (P) 2014-01-28 2014-04-08 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100612789
20221977 20175343 1.62 69.3 Palliative (P) 2016-08-20 2016-08-26 Cetuximab + Oxaliplatin + MdG Maint 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100127787
20222014 20175344 0 52.7 Palliative (P) null 2019-04-27 Capecitabine + Mitomycin 02 N CAPECITABINE + MITOMYCIN 100735318
20222039 20175346 null null null null 2019-01-31 FLUOROURACIL + MITOMYCIN 02 null FLUOROURACIL + MITOMYCIN 101227063